Literature DB >> 20668208

Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor.

Ying He1, Cheng Yang, Chelsea M Kirkmire, Zaijie Jim Wang.   

Abstract

MicroRNA has emerged as a critical regulator of neuronal functions. This study aimed to test whether let-7 microRNAs can regulate the mu opioid receptor (MOR) and opioid tolerance. Employing bioinformatics, we identified a let-7 binding site in the 3'-untranslated region (UTR) of MOR mRNA, which was experimentally confirmed as a direct target of let-7. The repressive regulation of MOR by let-7 was revealed using a LNA-let-7 inhibitor to knockdown let-7 in SH-SY5Y cells. Conversely, morphine significantly upregulated let-7 expression in SH-SY5Y cells and in a mouse model of opioid tolerance. The LNA-let-7 inhibitor decreased brain let-7 levels and partially attenuated opioid antinociceptive tolerance in mice. Although chronic morphine treatment did not change overall MOR transcript, polysome-associated mRNA declined in a let-7-dependent manner. let-7 was identified as a mediator translocating and sequestering MOR mRNA to P-bodies, leading to translation repression. These results suggest that let-7 plays an integral role in opioid tolerance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668208      PMCID: PMC2943348          DOI: 10.1523/JNEUROSCI.2419-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

2.  Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.

Authors:  P L Tao; P Y Law; H H Loh
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

3.  The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA.

Authors:  E G Moss; R C Lee; V Ambros
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

4.  Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.

Authors:  H N Bhargava; A Gulati
Journal:  Eur J Pharmacol       Date:  1990-11-13       Impact factor: 4.432

5.  Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.

Authors:  C S Wong; C H Cherng; H N Luk; S T Ho; C S Tung
Journal:  Eur J Pharmacol       Date:  1996-02-15       Impact factor: 4.432

6.  Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.

Authors:  J E Zadina; S L Chang; L J Ge; A J Kastin
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

7.  Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain.

Authors:  L J Sim; D E Selley; S I Dworkin; S R Childers
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

8.  CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone.

Authors:  M Brodsky; K Elliott; A Hynansky; C E Inturrisi
Journal:  Brain Res Bull       Date:  1995       Impact factor: 4.077

9.  Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.

Authors:  V C Yu; W Sadée
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.

Authors:  J B Wang; P S Johnson; A M Persico; A L Hawkins; C A Griffin; G R Uhl
Journal:  FEBS Lett       Date:  1994-01-31       Impact factor: 4.124

View more
  84 in total

Review 1.  Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

Authors:  Ivy Ka Man Law; David Miguel Padua; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

Review 2.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

3.  Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons.

Authors:  Reuben Saba; Peter H Störchel; Ayla Aksoy-Aksel; Frauke Kepura; Giordano Lippi; Tim D Plant; Gerhard M Schratt
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

Review 4.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

5.  Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence.

Authors:  J D Tapocik; M Solomon; M Flanigan; M Meinhardt; E Barbier; J R Schank; M Schwandt; W H Sommer; M Heilig
Journal:  Pharmacogenomics J       Date:  2012-05-22       Impact factor: 3.550

Review 6.  [Epigenetics and pain].

Authors:  E Niederberger
Journal:  Anaesthesist       Date:  2014-01       Impact factor: 1.041

7.  Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study.

Authors:  Jan L Bjersing; Maria I Bokarewa; Kaisa Mannerkorpi
Journal:  Rheumatol Int       Date:  2014-09-28       Impact factor: 2.631

8.  Synaptic microRNAs Coordinately Regulate Synaptic mRNAs: Perturbation by Chronic Alcohol Consumption.

Authors:  Dana Most; Courtney Leiter; Yuri A Blednov; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

Review 9.  Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders.

Authors:  Ernest T Chivero; Raghubendra Singh Dagur; Eric S Peeples; Susmita Sil; Ke Liao; Rong Ma; Liang Chen; Channabasavaiah B Gurumurthy; Shilpa Buch; Guoku Hu
Journal:  Cell Mol Life Sci       Date:  2021-04-05       Impact factor: 9.261

Review 10.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.